We have observed
8 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 16, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
FACTOR VII FUSION POLYPEPTIDES
FVIIA-STF COMPLEXES EXHIBITING EXOSITE-MEDIATED SUPER ACTIVITY
COAGULATION FACTOR VII POLYPEPTIDES
FACTOR VII CONJUGATES
PROCESS FOR PROTEIN PRODUCTION